SignatureFD’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,502
| Closed | -$276K | – | 3295 |
|
|
2021
Q2 | $276K | Buy |
1,502
+162
| +12% | +$29.8K | 0.01% | 541 |
|
|
2021
Q1 | $205K | Sell |
1,340
-207
| -13% | -$31.7K | 0.01% | 582 |
|
|
2020
Q4 | $242K | Buy |
1,547
+234
| +18% | +$36.6K | 0.01% | 476 |
|
|
2020
Q3 | $150K | Sell |
1,313
-76
| -5% | -$8.68K | 0.01% | 584 |
|
|
2020
Q2 | $156K | Buy |
1,389
+462
| +50% | +$51.9K | 0.01% | 535 |
|
|
2020
Q1 | $83K | Buy |
927
+292
| +46% | +$26.1K | 0.01% | 709 |
|
|
2019
Q4 | $69K | Sell |
635
-125
| -16% | -$13.6K | 0.01% | 862 |
|
|
2019
Q3 | $74K | Sell |
760
-62
| -8% | -$6.04K | 0.01% | 779 |
|
|
2019
Q2 | $108K | Buy |
822
+96
| +13% | +$12.6K | 0.01% | 598 |
|
|
2019
Q1 | $98K | Buy |
726
+154
| +27% | +$20.8K | 0.01% | 636 |
|
|
2018
Q4 | $56K | Buy |
572
+25
| +5% | +$2.45K | 0.01% | 804 |
|
|
2018
Q3 | $76K | Sell |
547
-21
| -4% | -$2.92K | 0.01% | 740 |
|
|
2018
Q2 | $71K | Buy |
568
+272
| +92% | +$34K | 0.01% | 738 |
|
|
2018
Q1 | $33K | Buy |
+296
| New | +$33K | ﹤0.01% | 887 |
|
|
2016
Q4 | – | Sell |
-479
| Closed | -$59K | – | 1385 |
|
|
2016
Q3 | $59K | Buy |
479
+164
| +52% | +$20.2K | 0.01% | 495 |
|
|
2016
Q2 | $37K | Sell |
315
-8
| -2% | -$940 | 0.01% | 548 |
|
|
2016
Q1 | $45K | Buy |
323
+61
| +23% | +$8.5K | 0.01% | 459 |
|
|
2015
Q4 | $50K | Buy |
262
+172
| +191% | +$32.8K | 0.01% | 369 |
|
|
2015
Q3 | $14K | Buy |
90
+72
| +400% | +$11.2K | ﹤0.01% | 616 |
|
|
2015
Q2 | $3K | Buy |
18
+2
| +13% | +$333 | ﹤0.01% | 853 |
|
|
2015
Q1 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 774 |
|